Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul R. Edick currently holds 500,000 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul R. Edick has been a net buyer of PDLI stock. They have purchased $1.6M and sold $0 worth of shares.
Paul R. Edick's most recent insider trade was on Jan 31, 2024, when they sold 500,000 shares at $0.00 per share.
Paul R. Edick serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 49 insider transactions totaling $1.6M over their tenure at the company.
Paul R. Edick holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Paul R. Edick has shown a buying trading pattern, with $1.6M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Paul R. Edick was on Nov 11, 2021, when they purchased $416.0K worth of XERS shares. This transaction involved 200,000 shares at $2.08 per share.
Paul R. Edick currently owns 500,000 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul R. Edick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul R. Edick has 49 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for Paul R. Edick and 40,000+ other insiders.